Stiff Mornings and New Research
For people whose joints stiffen with autoimmune disease, research into mesenchymal stem cells is drawing attention. Here is how that work relates to existing care and why long-term data matters.
- Autoimmune
- 2 min
06/29/2026
The Days That Feel Harder
Some mornings the joints simply do not cooperate. Fingers resist, knees ache and getting started takes longer than it should. For people with autoimmune joint disease, those days can arrive without warning, and fatigue often comes with them. When stiffness lingers despite regular treatment, it is natural to look at what else medicine is studying. Questions about new research are worth raising with your rheumatologist, who knows how your disease has behaved over time.
An Added Area of Study
Regenerative medicine is studied as an addition to existing care, with standard treatment staying in place. One part of the field focuses on mesenchymal stem cells, which send signals to injured or inflamed tissue. Researchers are studying whether those signals can help reduce swelling and influence how the immune system behaves around the joints. Trials are ongoing, and progress tends to come one study at a time.
Beyond Short-Term Relief
Many patients who explore regenerative options want more than a few good weeks. They are interested in research that looks at tissue and immune activity over longer periods. That is why careful observation matters: real patient results, recorded consistently over months, add to what longer studies show.
At Regeneration Clinic, follow-up includes check-ins at 1, 3, 6, 9 and 12 months after treatment.
Care That Starts With the Individual
Each patient’s condition, medication and goals are different, and a plan should reflect that. A medical evaluation decides whether treatment is appropriate, and results vary between patients.
The cells we use are mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory. Our team explains what the evidence shows, and what it does not yet show, before any decision is made.
06/29/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






